This school will focus on the contribution of gut-liver axis to a range of chronic liver diseases, the growing pertinence of antimicrobial resistance to cirrhosis, and manipulation of the gut microbiome as a novel approach to treatment (using faecal microbiota transplant amongst other techniques). This school aims to give an update over a number of key themes across the spectrum of the microbiome and liver disease, relevant to clinicians and scientists alike.